4
Changes in Ownership
Lexeo Therapeutics, Inc. Filed Acc 0001415889-25-009450
Chief Executive Officer acquired 2,128 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Townsend Richard Nolan Chief Executive Officer | 2025-03-14 | Grant or award | +2,128 | $2.61 | $5,554 | 222,247 | D |
Loading xslF345X05/form4-04012025_110414.xml…